TNF and inflammatory bowel disease: Gisbert Gisbert JP JP Chaparro Chaparro M M Predictors of primary response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in patients with inflammatory bowel disease: from Basic Science to Clinical Practice Predictors of primary response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in patients with inflammatory bowel disease: from Basic Science to Clinical Practice J. Crohns Colitis J. Crohns Colitis 2020 2020 14 14 694 694 709 709 10.1093/ecco-jcc/jjz195 10.1093/ecco-jcc/jjz195 supplied-pmid 31777929?